Virbac SA said it will defer the option to buy the remaining 49% stake in animal health and aquaculture company Centrovet Laboratories Inc. for three years.
The French company has held a 51% stake in Santiago, Chile-based Centrovet since November 2012.
Virbac said exercising the option in late 2017 would have added to the company's debt burden at a time when it is seeking to deleverage.
